Research advances in tumor diagnosis and early detection

This review explores recent advances in tumor diagnosis and early detection, focusing on cutting-edge developments in molecular diagnostic technologies, imaging techniques, and the integration of multi-omics data. Current tumor diagnostic methods have limitations in terms of sensitivity and specificity, particularly for early tumor detection. However, with continuous progress in research and emerging technologies, especially the advent of liquid biopsy, which enables the detection of circulating tumor DNA (ctDNA), exosomes, and tumor-educated platelets (TEPs), the sensitivity and accuracy of early cancer detection have significantly improved. Moreover, the combined application of artificial intelligence and high-resolution imaging technology has enhanced the precision of diagnosis. Despite these advances, challenges, such as the high cost of technology and difficulties in data integration, continue to impede widespread clinical adoption. Therefore, I believe that future research should prioritize the innovation of these technologies to improve their applicability for early detection across various cancer types, ultimately contributing to the advancement of personalized therapy.

Authors

Institutions

Publication Details

Journal
Asia-Pacific Journal of Oncology
Published
2024-09-13
DOI
https://doi.org/10.32948/ajo.2024.09.18
Citations
2
Primary Topic
Cancer Genomics and Diagnostics
Type
article
Field-Weighted Citation Impact
0.57
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Research advances in tumor diagnosis and early detection

Rodney Bradly
2 citations
Asia-Pacific Journal of Oncology
Cancer Genomics and Diagnostics
0.57
article

Research advances in tumor diagnosis and early detection

Rodney Bradly
article en
2 citations

Abstract

This review explores recent advances in tumor diagnosis and early detection, focusing on cutting-edge developments in molecular diagnostic technologies, imaging techniques, and the integration of multi-omics data. Current tumor diagnostic methods have limitations in terms of sensitivity and specificity, particularly for early tumor detection. However, with continuous progress in research and emerging technologies, especially the advent of liquid biopsy, which enables the detection of circulating tumor DNA (ctDNA), exosomes, and tumor-educated platelets (TEPs), the sensitivity and accuracy of early cancer detection have significantly improved. Moreover, the combined application of artificial intelligence and high-resolution imaging technology has enhanced the precision of diagnosis. Despite these advances, challenges, such as the high cost of technology and difficulties in data integration, continue to impede widespread clinical adoption. Therefore, I believe that future research should prioritize the innovation of these technologies to improve their applicability for early detection across various cancer types, ultimately contributing to the advancement of personalized therapy.

Asia-Pacific Journal of Oncology
Shawnee State University (US)
Openalex Percentile: Top 31%
Cancer Genomics and Diagnostics
0.57
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.